Oraya Therapeutics, Inc. is a privately-held medical technology company developing radiosurgical treatments for eye diseases. Founded in 2006, Oraya is funded by Essex Woodlands Health Ventures, Synergy Life Science Partners, Scale Venture Partners, and Domain Associates. The company's first commercial application, the IRay™ system, is currently undergoing clinical trials for the treatment of wet age-related macular degeneration (AMD).